Focal Biosciences
PrivateLast Round
Seed
Oct 11, 2022
Company Overview
Focal Biosciences operates in Healthcare & Life Sciences and is based in Villigen. Its latest recorded funding round was a Seed round in October 2022.
Focal Biosciences is a biotechnology company that develops a cellular reprogramming discovery platform to identify small-molecule therapeutics for age-related chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Focal Biosciences Comparables
Compare Focal Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clock.bio | 85% | |
| TippingPoint Biosciences | 81% | |
| Forcyte Biotechnologies | 77% |
For institutional investors. Book with your work email.
Focal Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Focal Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paul Scherrer Institute | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 11, 2022
Seed round with participation from Paul Scherrer Institute.
For institutional investors. Book with your work email.
Focal Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Focal Biosciences's valuation, stock price, and market status.
Is Focal Biosciences a public or private company?
Focal Biosciences is a private company.
What is the current stock price of Focal Biosciences?
Focal Biosciences is a private company, so its shares have no public market price. Caplight tracks Focal Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Focal Biosciences worth (valuation)?
Valuation information for Focal Biosciences is not publicly available.
Can I buy Focal Biosciences stock?
Focal Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Focal Biosciences's last funding round?
Focal Biosciences's most recent funding round was Seed on October 11, 2022.
Who are the main investors in Focal Biosciences?
Key investors in Focal Biosciences include Paul Scherrer Institute.
Will Focal Biosciences IPO soon?
No public IPO plans have been announced for Focal Biosciences.
How can I track Focal Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Focal Biosciences's shares on secondary markets.